中科江南(301153.SZ):支付電子化業務是公司傳統的、佔有較高收入比例的業務
格隆匯6月28日丨中科江南(301153.SZ)近期在接待機構調研時表示,支付電子化業務主要是以國庫集中支付電子化管理為核心、利用公司電子憑證庫相關技術,為客户提供產品和服務的整體解決方案,具有高安全、高穩定、不可篡改等優勢。該系統在財政部門、預算單位、人民銀行及代理銀行之間取消紙質憑證和單據流轉,依據電子指令辦理財政資金支付及清算業務,實現財政資金安全高效運行。支付電子化業務是公司傳統的、佔有較高收入比例的業務,未來發展空間在積極拓點、新增銀行用户、下沉市場推廣以及升級改造對標等方面。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.